Agenda - Thursday, January 11, 2018

Thursday, January 11, 2018

9:00 - 10:45am
Session 1: What is Cardiac Recovery?
Chairpersons: James Fang, MD,
U of Utah, Salt Lake City and Donald Lappe, MD, Intermountain Medical Center, Salt Lake City

Topic

 Speaker

1. Focus on the myocardium

Jane E. Wilcox, MD, MSc, Northwestern University, Feinberg School of Medicine

2. The role of peripheral and systemic influences: hepatic, renal, and vascular function.

Javed Butler, MD, MPH Stony Brook, New York, NY      

3. Understanding recovery through circulating biomarkers.

Gary Michael Felker, MD, Duke University, Durham, NC

4. New insights into cardiac recovery using advanced imaging modalities.

Jeroen J. Bax, MD, Leiden University Medical Centre, Leiden, The Netherlands, President European Society of Cardiology (ESC) 2016-2018

10:45 - 11:30am
KEYNOTE ADDRESS:
HF-recovered-EF: What Does It Mean?
Milton Packer, MD,
Distinguished Scholar in Cardiovascular Science 
Baylor University Medical Center

11:30-12:30pm Lunch - Moderated Poster Session
Poster discussants: Rami Alharethi, MD Intermountain Medical Center - Rashmee Shah, MD U of Utah - Dipayan Chaudhuri, MD U of Utah

12:45 -2:30pm
Session 2: Myocardial Recovery Innovation 
Chairpersons: Kirk Knowlton, MD Intermountain Medical Center, Salt Lake City - Jared Rutter, PhD, U of Utah, Salt Lake City

Topic

Speaker

1.What can we learn from recovering the donor heart.

Ulrich P. Jorde, MD, Montefiore/Albert Einstein

2. Regenerative medicine driving myocardial recovery: bench to bedside

Hesham Sadek, MDPhD UT Southwestern, Dallas, TX

3. Title TBD

Joseph Yost, MD, U of Utah, Salt Lake City, UT

4. Future directions from cardiovascular genetics.

Martin Tristani-Firouzi, MD, U of Utah/ Primary Children’s/CVRTI, Salt Lake City, UT

5. Discoveries from the cardiac metabolism front: therapeutic implications. 

Konstantinos Drosatos, PhD, Temple University, Philadelphia

BREAK -2:30 - 3:00pm

3:00 - 5:30pm
Session 3: How Can HFpEF Inform Us About Myocardial Recovery And Vice Versa.
Chairpersons: Nancy K. Sweitzer, MD U of Arizona, Tucson John Ryan, MD, U of Utah, Salt Lake City

Session's central theme: 
HFpEF and HFrEF: distinct phenotypes or continuum?

Topic

Speaker

1. Invasive cardiopulmonary exercise testing to predict outcomes.

Aaron Waxman, MD, PhD Brigham and Women's Hospital, Boston, MA

2.Understanding the role of periphery.

Russell S. Richardson, PhD, U of Utah & VA Medical Center, Salt Lake City, UT

3. Leveraging the strengths of advanced imaging to provide precision care.

Amit Patel, MD, U of Chicago Chicago, IL

4. Back to the animal models? 

Flora Sam, MD, Boston University, Boston, MA

5. Time to abandon ejection fraction and other new ideas. 

Mathew Maurer, MD, Columbia University, Chicago, IL

Focused Panel discussion (chairs & speakers): “Are Systolic and Diastolic Heart Failure Overlapping or Distinct Phenotypes Within the Heart Failure Spectrum”

7:00 - 9:30 pm
Symposium Dinner

Previous Conferences